| scholarly article | Q13442814 |
| P50 | author | Kathryn Fitzgerald | Q82857957 |
| Kathryn M. Anastos | Q100301637 | ||
| Pauline M. Maki | Q37386805 | ||
| P2093 | author name string | Robert C Kaplan | |
| Philip J Norris | |||
| Lorie Benning | |||
| Gayle Springer | |||
| Yanxun Xu | |||
| Leah H Rubin | |||
| Deborah R Gustafson | |||
| Sheila M Keating | |||
| Seble Kassaye | |||
| Dionna W Williams | |||
| Raha Dastgheyb | |||
| Victor G Valcour | |||
| Xuzhi Wang | |||
| P2860 | cites work | The role of immune dysfunction in the pathophysiology of autism | Q22252518 |
| Cognition and depression: current status and future directions | Q22255648 | ||
| T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions | Q24562400 | ||
| HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications | Q24607794 | ||
| HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors | Q24631745 | ||
| HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment | Q26766448 | ||
| Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition | Q26771954 | ||
| Vascular contributions to cognitive impairment and dementia including Alzheimer's disease | Q26852882 | ||
| Type I interferon: friend or foe? | Q28293186 | ||
| Immunity, atherosclerosis and cardiovascular disease | Q28688590 | ||
| The immunology of stroke: from mechanisms to translation | Q29620066 | ||
| T cell exhaustion | Q29620463 | ||
| Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide | Q30490518 | ||
| High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease | Q30973354 | ||
| A meta-analysis on the impact of psychiatric disorders and maltreatment on cognition. | Q50576982 | ||
| Sex Differences in HIV Infection. | Q52674721 | ||
| Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation | Q58104425 | ||
| Neuroimmune Activation Drives Multiple Brain States | Q58694298 | ||
| Traumatic Brain Injury in Aged Mice Induces Chronic Microglia Activation, Synapse Loss, and Complement-Dependent Memory Deficits | Q60939575 | ||
| HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy | Q83903480 | ||
| Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women | Q88753310 | ||
| Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms | Q90111815 | ||
| Empiric neurocognitive performance profile discovery and interpretation in HIV infection | Q90295652 | ||
| Human Immunodeficiency Virus Type 1 RNA Detected in the Central Nervous System (CNS) After Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells | Q90609804 | ||
| Neuroimmune Communication in Health and Disease | Q90955543 | ||
| Longitudinal course of cognitive function across treatment in patients with MDD: A meta-analysis | Q91503922 | ||
| HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression? | Q92711670 | ||
| The Women's Interagency HIV Study. WIHS Collaborative Study Group | Q95805016 | ||
| Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C. | Q33408423 | ||
| HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy. | Q33513977 | ||
| HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality | Q33618542 | ||
| Interactions between macrophages and brain microvascular endothelial cells: role in pathogenesis of HIV-1 infection and blood - brain barrier function | Q33797111 | ||
| Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia | Q33911855 | ||
| The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench | Q34045522 | ||
| Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy | Q34147129 | ||
| Neurocognition, health-related reading literacy, and numeracy in medication management for HIV infection | Q34218687 | ||
| CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders | Q34376412 | ||
| Targeting of type I interferon in systemic autoimmune diseases | Q34451758 | ||
| Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy | Q34588169 | ||
| Endothelial dysfunction in insulin resistance and type 2 diabetes | Q34655075 | ||
| HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research | Q34721127 | ||
| JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals | Q35005863 | ||
| Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism | Q35057044 | ||
| A neuropsychological investigation of multitasking in HIV infection: implications for everyday functioning | Q35074561 | ||
| Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease | Q35104006 | ||
| The two faces of interferon-γ in cancer | Q35269015 | ||
| Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription | Q35780194 | ||
| Oxidative stress and aberrant signaling in aging and cognitive decline | Q35987295 | ||
| Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. | Q35990287 | ||
| Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome | Q36012867 | ||
| Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis | Q36020991 | ||
| Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. | Q36072424 | ||
| Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy | Q36498230 | ||
| Cognitive function following stroke and vascular cognitive impairment | Q36653076 | ||
| Medication and finance management among HIV-infected adults: the impact of age and cognition | Q36740141 | ||
| Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy. | Q36775142 | ||
| Microvascular Dysfunction and Cognitive Impairment. | Q36839870 | ||
| Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function | Q36907335 | ||
| Neurocognitive disturbances in HIV. | Q37073656 | ||
| Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection. | Q37247467 | ||
| Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy | Q37354047 | ||
| A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals | Q37416972 | ||
| Endothelial dysfunction, vascular disease and stroke: the ARTICO study. | Q37431225 | ||
| Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues | Q37587740 | ||
| Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction | Q37781306 | ||
| The interferon signature in autoimmune diseases | Q38068288 | ||
| Atherosclerosis and interferon-γ: new insights and therapeutic targets | Q38126725 | ||
| Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease | Q38210113 | ||
| Cognitive consequences of a sustained monocyte type 1 IFN response in HIV-1 infection | Q38214994 | ||
| Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND) | Q38258410 | ||
| Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition | Q38490628 | ||
| Persistent HIV-1 replication during antiretroviral therapy | Q38808266 | ||
| Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging | Q38994143 | ||
| Type I Interferon in Chronic Virus Infection and Cancer. | Q39349338 | ||
| Cognitive trajectories over 4 years among HIV-infected women with optimal viral suppression | Q40042543 | ||
| Exploratory Factor Analysis With Small Sample Sizes. | Q40120698 | ||
| The impact of HIV-associated neuropsychological impairment on everyday functioning | Q40509922 | ||
| HIV reservoirs as obstacles and opportunities for an HIV cure | Q41216521 | ||
| Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C. | Q41682518 | ||
| Resolving postoperative neuroinflammation and cognitive decline. | Q43014459 | ||
| Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system | Q43859445 | ||
| The role of the TLR4 signaling pathway in cognitive deficits following surgery in aged rats | Q44379175 | ||
| The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition | Q44840038 | ||
| Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy | Q45721932 | ||
| IRF3 and type I interferons fuel a fatal response to myocardial infarction. | Q46039774 | ||
| Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals | Q46519431 | ||
| Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa | Q46911957 | ||
| Postoperative impairment of cognitive function in old mice: a possible role for neuroinflammation mediated by HMGB1, S100B, and RAGE. | Q47900040 | ||
| Neuroinflammatory cytokine signaling and Alzheimer's disease | Q48514196 | ||
| Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease | Q48584697 | ||
| CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection | Q48714127 | ||
| HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape | Q48841023 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 20 | |
| P577 | publication date | 2020-04-24 | |
| P1433 | published in | Frontiers in Integrative Neuroscience | Q15817251 |
| P1476 | title | Early Inflammatory Signatures Predict Subsequent Cognition in Long-Term Virally Suppressed Women With HIV | |
| P478 | volume | 14 |
Search more.